Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
459
1.770
 Why?
Endometrial Neoplasms
5
2015
143
0.810
 Why?
Gynecology
5
2020
52
0.770
 Why?
Genital Neoplasms, Female
2
2020
48
0.720
 Why?
Gene Expression Regulation, Neoplastic
10
2019
868
0.710
 Why?
Cystadenocarcinoma, Serous
4
2021
73
0.670
 Why?
Infection Control
1
2020
45
0.630
 Why?
Ethics, Medical
1
2020
46
0.620
 Why?
Communication
1
2020
263
0.560
 Why?
Conflict of Interest
3
2016
24
0.550
 Why?
Medical Oncology
3
2020
97
0.540
 Why?
Uterus
1
2018
81
0.540
 Why?
Robotics
2
2014
43
0.520
 Why?
Pneumonia, Viral
1
2020
177
0.520
 Why?
Coronavirus Infections
1
2020
188
0.510
 Why?
Peptides
3
2015
234
0.510
 Why?
Receptors, Estrogen
5
2017
134
0.510
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.480
 Why?
Fallopian Tube Neoplasms
2
2013
15
0.480
 Why?
Pandemics
1
2020
595
0.460
 Why?
Antineoplastic Agents, Hormonal
1
2015
56
0.460
 Why?
Glycoproteins
1
2015
121
0.460
 Why?
Gynecologic Surgical Procedures
2
2014
29
0.450
 Why?
Neoplastic Stem Cells
1
2015
90
0.450
 Why?
Adenocarcinoma
2
2015
405
0.440
 Why?
Antigens, CD
1
2015
217
0.430
 Why?
Salpingectomy
1
2013
6
0.390
 Why?
Female
34
2023
28782
0.390
 Why?
Pelvic Neoplasms
1
2013
14
0.390
 Why?
General Surgery
1
2014
108
0.390
 Why?
Peritoneal Neoplasms
2
2011
68
0.390
 Why?
MicroRNAs
4
2021
397
0.390
 Why?
Estrogens
2
2012
224
0.380
 Why?
Clinical Trials as Topic
2
2007
466
0.360
 Why?
Medicare Part B
1
2011
5
0.360
 Why?
Professional Corporations
1
2011
1
0.360
 Why?
Marketing of Health Services
1
2011
7
0.350
 Why?
Reimbursement Mechanisms
1
2011
24
0.350
 Why?
Physicians
2
2016
242
0.350
 Why?
Social Responsibility
1
2011
27
0.350
 Why?
Receptors, Progesterone
4
2015
68
0.350
 Why?
Cell Line, Tumor
11
2016
1470
0.350
 Why?
Trust
1
2011
62
0.340
 Why?
Humans
42
2023
53230
0.330
 Why?
Carcinoma, Large Cell
1
2010
17
0.330
 Why?
Carcinoma, Neuroendocrine
1
2010
27
0.330
 Why?
Health Care Reform
1
2010
22
0.330
 Why?
Interprofessional Relations
1
2011
95
0.320
 Why?
Physician-Patient Relations
1
2011
146
0.320
 Why?
Breast Neoplasms
4
2012
1222
0.310
 Why?
Uterine Neoplasms
2
2019
57
0.280
 Why?
Transplantation, Heterologous
2
2012
78
0.270
 Why?
Uterine Cervical Neoplasms
1
2010
301
0.270
 Why?
Physician's Role
2
2011
49
0.260
 Why?
MAP Kinase Kinase 4
1
2007
30
0.260
 Why?
Apoptosis
5
2016
1139
0.260
 Why?
Advance Directives
1
2007
27
0.250
 Why?
Genes, Tumor Suppressor
1
2007
73
0.250
 Why?
Patient Dropouts
1
2007
52
0.250
 Why?
Gene Expression Regulation, Enzymologic
1
2007
180
0.240
 Why?
Claudin-4
2
2016
7
0.230
 Why?
Receptors, Transforming Growth Factor beta
1
2005
29
0.230
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1043
0.220
 Why?
Ovary
1
2004
103
0.210
 Why?
Hysterectomy
2
2014
91
0.210
 Why?
Epithelial Cells
1
2004
218
0.200
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
579
0.200
 Why?
Aged
11
2021
10429
0.190
 Why?
Neoplasm Staging
4
2021
774
0.190
 Why?
Middle Aged
12
2021
13419
0.180
 Why?
Gene Expression Profiling
3
2019
1112
0.180
 Why?
Cisplatin
2
2015
282
0.180
 Why?
Immunohistochemistry
6
2017
975
0.170
 Why?
Cell Movement
3
2016
279
0.160
 Why?
Resource Allocation
1
2020
14
0.160
 Why?
Standard of Care
1
2020
18
0.160
 Why?
Disclosure
2
2016
40
0.160
 Why?
Loss of Heterozygosity
2
2013
78
0.160
 Why?
Lymphatic Metastasis
2
2010
211
0.160
 Why?
Leiomyoma
1
2019
21
0.150
 Why?
Leiomyosarcoma
1
2019
22
0.150
 Why?
Neoplasm Invasiveness
3
2015
281
0.150
 Why?
Early Detection of Cancer
1
2021
190
0.150
 Why?
Xenograft Model Antitumor Assays
4
2012
228
0.150
 Why?
RNA-Binding Proteins
2
2019
133
0.140
 Why?
Informed Consent
3
2004
94
0.140
 Why?
Critical Care
1
2020
215
0.140
 Why?
Death
1
2018
23
0.140
 Why?
Living Donors
1
2018
27
0.140
 Why?
Palliative Care
1
2020
195
0.140
 Why?
Neoplasms, Glandular and Epithelial
2
2015
42
0.140
 Why?
Carcinosarcoma
1
2017
18
0.140
 Why?
Microfilament Proteins
1
2017
44
0.130
 Why?
Sequence Analysis, RNA
1
2017
96
0.130
 Why?
Mice, Nude
3
2012
232
0.120
 Why?
United States
4
2016
5409
0.120
 Why?
Industry
1
2016
16
0.120
 Why?
Adult
7
2021
14534
0.120
 Why?
Keratin-5
1
2015
2
0.120
 Why?
Carrier Proteins
1
2017
315
0.120
 Why?
Cell Count
1
2015
141
0.120
 Why?
Receptors, Androgen
1
2015
48
0.120
 Why?
Cell Proliferation
4
2015
1031
0.120
 Why?
Prognosis
4
2017
2118
0.110
 Why?
Neoplasm Seeding
1
2014
4
0.110
 Why?
Genetic Privacy
2
2004
3
0.110
 Why?
Alanine
1
2014
43
0.110
 Why?
Triazines
1
2014
25
0.110
 Why?
Endometrium
1
2014
43
0.100
 Why?
Genes, BRCA2
1
2013
13
0.100
 Why?
Genes, BRCA1
1
2013
19
0.100
 Why?
Mice
6
2016
5982
0.100
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.100
 Why?
Health Care Costs
2
2013
178
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.100
 Why?
DNA Methylation
3
2023
592
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
32
0.100
 Why?
DNA-Binding Proteins
2
2013
423
0.090
 Why?
Lymph Nodes
1
2014
252
0.090
 Why?
Paclitaxel
1
2012
91
0.090
 Why?
Antibodies, Neoplasm
1
2012
27
0.090
 Why?
Judicial Role
1
2011
6
0.090
 Why?
Coercion
1
2011
9
0.090
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.090
 Why?
Personal Autonomy
1
2011
18
0.090
 Why?
Women
1
2011
30
0.090
 Why?
Prejudice
1
2011
37
0.090
 Why?
Homeodomain Proteins
1
2012
81
0.090
 Why?
Politics
1
2011
28
0.090
 Why?
Quality of Health Care
1
2013
189
0.090
 Why?
Violence
1
2011
65
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
5
0.090
 Why?
Taxoids
1
2011
38
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
23
0.080
 Why?
RNA, Messenger
2
2012
1133
0.080
 Why?
Obstetrics
1
2011
87
0.080
 Why?
Immunoenzyme Techniques
1
2010
134
0.080
 Why?
Organ Specificity
1
2010
115
0.080
 Why?
Models, Statistical
1
2011
229
0.080
 Why?
Cesarean Section
1
2011
158
0.080
 Why?
Neoplasm Recurrence, Local
1
2014
647
0.080
 Why?
Alcohol Drinking
1
2011
241
0.080
 Why?
Blotting, Western
1
2010
587
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
412
0.080
 Why?
Societies, Medical
1
2010
207
0.070
 Why?
Transfection
2
2012
359
0.070
 Why?
Phosphorylation
2
2008
533
0.070
 Why?
Animals
6
2016
13526
0.070
 Why?
Aging
1
2013
714
0.070
 Why?
Aged, 80 and over
4
2021
3494
0.070
 Why?
Alleles
2
2006
277
0.070
 Why?
Antineoplastic Agents
1
2015
1232
0.070
 Why?
Case-Control Studies
2
2014
1212
0.070
 Why?
Chimera
1
2007
10
0.060
 Why?
CpG Islands
1
2007
114
0.060
 Why?
MAP Kinase Signaling System
1
2007
127
0.060
 Why?
Genomic Imprinting
1
2006
11
0.060
 Why?
Insulin-Like Growth Factor II
1
2006
18
0.060
 Why?
RNA, Untranslated
1
2006
15
0.060
 Why?
Base Sequence
1
2007
620
0.060
 Why?
Health Services Accessibility
1
2010
477
0.060
 Why?
Molecular Sequence Data
1
2007
759
0.060
 Why?
Models, Biological
2
2008
737
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
North Carolina
1
2005
53
0.060
 Why?
Carcinoma
1
2006
136
0.060
 Why?
Databases, Nucleic Acid
1
2004
10
0.060
 Why?
Telomerase
1
2004
26
0.050
 Why?
Promoter Regions, Genetic
1
2007
465
0.050
 Why?
Tumor Burden
2
2016
132
0.050
 Why?
RNA Interference
2
2016
181
0.050
 Why?
Polymorphism, Genetic
1
2005
181
0.050
 Why?
RNA, Small Interfering
2
2016
214
0.050
 Why?
Cell Survival
2
2016
600
0.050
 Why?
Family Health
1
2004
78
0.050
 Why?
Genetic Counseling
1
2004
44
0.050
 Why?
Genomics
1
2004
271
0.050
 Why?
Epigenesis, Genetic
1
2006
412
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
13
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Genetic Predisposition to Disease
1
2005
533
0.050
 Why?
Cell Line
1
2004
1016
0.050
 Why?
Mice, SCID
2
2012
180
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Biotechnology
1
2002
15
0.050
 Why?
Drug Industry
1
2002
39
0.040
 Why?
Research Support as Topic
1
2002
44
0.040
 Why?
Research Subjects
1
2002
53
0.040
 Why?
Neoplasm Grading
1
2021
128
0.040
 Why?
Patient Selection
1
2002
273
0.040
 Why?
Cooperative Behavior
1
2002
233
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
11
0.040
 Why?
Cytoskeletal Proteins
1
2019
46
0.040
 Why?
Microtubule-Associated Proteins
1
2019
61
0.040
 Why?
Risk Assessment
1
2023
1368
0.040
 Why?
Biomedical Research
1
2002
267
0.040
 Why?
Cell Cycle Proteins
1
2019
170
0.040
 Why?
Sensitivity and Specificity
1
2019
867
0.030
 Why?
Cohort Studies
1
2021
1557
0.030
 Why?
Caspase 3
1
2016
92
0.030
 Why?
Diagnosis, Differential
1
2019
1038
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Retrospective Studies
2
2021
6819
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
56
0.030
 Why?
Prospective Studies
1
2021
2411
0.030
 Why?
HEK293 Cells
1
2015
235
0.030
 Why?
Exosomes
1
2015
58
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
9
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
187
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
4017
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
189
0.030
 Why?
Disease-Free Survival
1
2014
466
0.020
 Why?
MCF-7 Cells
1
2013
65
0.020
 Why?
Germ-Line Mutation
1
2013
67
0.020
 Why?
Amino Acid Substitution
1
2013
79
0.020
 Why?
Homologous Recombination
1
2013
45
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
350
0.020
 Why?
Karyotyping
1
2012
77
0.020
 Why?
Extracellular Matrix Proteins
1
2013
69
0.020
 Why?
Anoikis
1
2012
9
0.020
 Why?
Transduction, Genetic
1
2012
44
0.020
 Why?
Tubulin
1
2012
22
0.020
 Why?
Mice, Inbred NOD
1
2012
90
0.020
 Why?
Databases, Factual
1
2016
742
0.020
 Why?
Tamoxifen
1
2012
60
0.020
 Why?
DNA Fingerprinting
1
2012
61
0.020
 Why?
Signal Transduction
2
2011
1748
0.020
 Why?
Cell Adhesion
1
2012
163
0.020
 Why?
Antibody Specificity
1
2012
36
0.020
 Why?
Amino Acid Sequence
1
2013
563
0.020
 Why?
Perioperative Period
1
2011
21
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
228
0.020
 Why?
Estradiol
1
2012
215
0.020
 Why?
Disease Models, Animal
1
2016
1517
0.020
 Why?
Microtubules
1
2011
35
0.020
 Why?
Cell Cycle Checkpoints
1
2011
32
0.020
 Why?
Gene Expression
1
2013
618
0.020
 Why?
Mitosis
1
2011
86
0.020
 Why?
Regression Analysis
1
2011
391
0.020
 Why?
HeLa Cells
1
2011
243
0.020
 Why?
Disease Progression
1
2012
880
0.020
 Why?
Cells, Cultured
1
2013
1569
0.020
 Why?
Severity of Illness Index
1
2011
1049
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
57
0.020
 Why?
Mutation
1
2013
1337
0.020
 Why?
Protein Kinases
1
2008
72
0.020
 Why?
Tumor Cells, Cultured
1
2008
441
0.020
 Why?
Cell Nucleus
1
2008
187
0.020
 Why?
Transcriptional Activation
1
2006
128
0.010
 Why?
DNA, Neoplasm
1
2006
146
0.010
 Why?
Protein Structure, Tertiary
1
2006
252
0.010
 Why?
Binding Sites
1
2006
373
0.010
 Why?
Repressor Proteins
1
2006
149
0.010
 Why?
Pregnancy
1
2011
2608
0.010
 Why?
Truth Disclosure
1
2004
15
0.010
 Why?
Genetic Diseases, Inborn
1
2004
23
0.010
 Why?
Male
1
2011
27435
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department